These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
126 related articles for article (PubMed ID: 2841081)
1. Expression of coxsackievirus B3 capsid proteins in Escherichia coli and generation of virus-specific antisera. Werner S; Klump WM; Schönke H; Hofschneider PH; Kandolf R DNA; 1988 Jun; 7(5):307-16. PubMed ID: 2841081 [TBL] [Abstract][Full Text] [Related]
2. Expression of Coxsackievirus B4 proteins VP0 and 2C in Escherichia coli and generation of virus protein recognizing antisera. Härkönen T; Hovi T; Roivainen M J Virol Methods; 1997 Dec; 69(1-2):147-58. PubMed ID: 9504760 [TBL] [Abstract][Full Text] [Related]
3. Cloning and expression of coxsakievirus B3 viral protein-1 in E. coli. Maghsoudi N; Khalilpour A; Kamali M; Zeinoddini M Iran Biomed J; 2007 Jul; 11(3):147-52. PubMed ID: 18051774 [TBL] [Abstract][Full Text] [Related]
4. Investigation of the coxsackievirus B3 nonstructural proteins 2B, 2C, and 3AB: generation of specific polyclonal antisera and detection of replicating virus in infected tissue. Hohenadl C; Klingel K; Rieger P; Hofschneider PH; Kandolf R J Virol Methods; 1994 May; 47(3):279-95. PubMed ID: 8071417 [TBL] [Abstract][Full Text] [Related]
5. Characterization of hepatitis A virus capsid proteins with antisera raised to recombinant antigens. Ross BC; Anderson DA J Virol Methods; 1991 May; 32(2-3):213-20. PubMed ID: 1651950 [TBL] [Abstract][Full Text] [Related]
6. Mapping of a neutralizing antigenic site of Coxsackievirus B4 by construction of an antigen chimera. Reimann BY; Zell R; Kandolf R J Virol; 1991 Jul; 65(7):3475-80. PubMed ID: 1645779 [TBL] [Abstract][Full Text] [Related]
7. Expression of the VP3-VP1 sequence of foot-and-mouth disease virus in Escherichia coli. Rossetti ML; Raupp RM; Farias SE; Ferreira LF; Zaha A Braz J Med Biol Res; 1993 Jun; 26(6):591-603. PubMed ID: 7504968 [TBL] [Abstract][Full Text] [Related]
8. Complete nucleotide sequence of infectious Coxsackievirus B3 cDNA: two initial 5' uridine residues are regained during plus-strand RNA synthesis. Klump WM; Bergmann I; Müller BC; Ameis D; Kandolf R J Virol; 1990 Apr; 64(4):1573-83. PubMed ID: 2157045 [TBL] [Abstract][Full Text] [Related]
9. Expression of an antigenic adenovirus epitope in a group B coxsackievirus. Höfling K; Tracy S; Chapman N; Kim KS; Smith Leser J J Virol; 2000 May; 74(10):4570-8. PubMed ID: 10775593 [TBL] [Abstract][Full Text] [Related]
10. Immunogenicity of a DNA vaccine for coxsackievirus B3 in mice: protective effects of capsid proteins against viral challenge. Kim JY; Jeon ES; Lim BK; Kim SM; Chung SK; Kim JM; Park SI; Jo I; Nam JH Vaccine; 2005 Feb; 23(14):1672-9. PubMed ID: 15705471 [TBL] [Abstract][Full Text] [Related]
11. An infectious cDNA copy of the genome of a non-cardiovirulent coxsackievirus B3 strain: its complete sequence analysis and comparison to the genomes of cardiovirulent coxsackieviruses. Chapman NM; Tu Z; Tracy S; Gauntt CJ Arch Virol; 1994; 135(1-2):115-30. PubMed ID: 8198437 [TBL] [Abstract][Full Text] [Related]
12. Recombinant proteins VP1 and VP3 of hepatitis A virus prime for neutralizing response. Gauss-Müller V; Zhou MQ; von der Helm K; Deinhardt F J Med Virol; 1990 Aug; 31(4):277-83. PubMed ID: 2176673 [TBL] [Abstract][Full Text] [Related]
13. Infectious bursal disease virus polyprotein processing does not involve cellular proteases. Kibenge FS; Qian B; Cleghorn JR; Martin CK Arch Virol; 1997; 142(12):2401-19. PubMed ID: 9672603 [TBL] [Abstract][Full Text] [Related]
14. Mutations in the poliovirus P1 capsid precursor at arginine residues VP4-ARG34, VP3-ARG223, and VP1-ARG129 affect virus assembly and encapsidation of genomic RNA. Ansardi DC; Luo M; Morrow CD Virology; 1994 Feb; 199(1):20-34. PubMed ID: 8116243 [TBL] [Abstract][Full Text] [Related]
15. Production of cross-reactive peptide antibodies against viral capsid proteins of human enterovirus B to apply diagnostic reagent. Jeong SY; Ahn J; Cho YJ; Kim YJ; Kim DS; Jee Y; Lee H; Nam JH Microbiol Immunol; 2007; 51(11):1091-8. PubMed ID: 18037786 [TBL] [Abstract][Full Text] [Related]
16. Development of a enterovirus diagnostic assay system for diagnosis of viral myocarditis in humans. Lim BK; Ju ES; Lao DH; Yun SH; Lee YJ; Kim DK; Jeon ES Microbiol Immunol; 2013 Apr; 57(4):281-7. PubMed ID: 23586632 [TBL] [Abstract][Full Text] [Related]
17. Susceptibility of coxsackievirus B3 laboratory strains and clinical isolates to the capsid function inhibitor pleconaril: antiviral studies with virus chimeras demonstrate the crucial role of amino acid 1092 in treatment. Schmidtke M; Hammerschmidt E; Schüler S; Zell R; Birch-Hirschfeld E; Makarov VA; Riabova OB; Wutzler P J Antimicrob Chemother; 2005 Oct; 56(4):648-56. PubMed ID: 16150864 [TBL] [Abstract][Full Text] [Related]
18. [Gene cloning and immunogenicity analysis of the structural proteins VP1-VP4 of enterovirus 71]. Song YB; Yu N; He SJ; Chen XX; Wang B; Che XY; Zeng QY Nan Fang Yi Ke Da Xue Xue Bao; 2011 Nov; 31(11):1846-50. PubMed ID: 22126762 [TBL] [Abstract][Full Text] [Related]
19. A single amino acid substitution in the capsid protein VP1 of coxsackievirus B3 (CVB3) alters plaque phenotype in Vero cells but not cardiovirulence in a mouse model. Zhang H; Blake NW; Ouyang X; Pandolfino YA; Morgan-Capner P; Archard LC Arch Virol; 1995; 140(5):959-66. PubMed ID: 7605207 [TBL] [Abstract][Full Text] [Related]
20. The structure of coxsackievirus B3 at 3.5 A resolution. Muckelbauer JK; Kremer M; Minor I; Diana G; Dutko FJ; Groarke J; Pevear DC; Rossmann MG Structure; 1995 Jul; 3(7):653-67. PubMed ID: 8591043 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]